Silicon Prairie News
Goldenrod Therapeutics raises $6.5 million to test UNMC-created drug that could change modern medicine
Incubated by Houston-based Fannin Innovation Studio, the 11h drug created in Nebraska will move toward phase 1 clinical trials in humans. If successful, it could serve as a miracle treatment for…
Read the original at Silicon Prairie NewsMore audio from Silicon Prairie News
-
5mPrairie Portraits: Corrine Wardian
The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and entrepreneurship ecosystem.
-
5mPrairie Portraits: Taylor Korensky
The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and entrepreneurship ecosystem.
-
4mPrairie Portraits: Kristin Klaus
The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and entrepreneurship ecosystem.
-
9mSBIR funding is back: Here’s what startup founders need to know
After a six-month lapse, these federal grants are available again — with new rules on foreign ties, proposal limits and opportunities for additional money.
-
5mPrairie Portraits: Jorden Gershenson
The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and entrepreneurship ecosystem.